Cycurion, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 06/30/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $15.1M | — | $17.8M | $19.4M | — |
| Cost of revenue | $13.5M | — | $14.1M | $16.7M | — |
| Gross profit | $1.6M | — | $3.6M | $2.6M | — |
| Selling, general & administrative | $9.3M | — | $1.2M | $2.3M | — |
| Research and development | — | — | $0 | $0 | — |
| Operating expenses | $25.0M | — | $1.2M | — | — |
| Operating income | -$23.4M | — | $2.4M | $326,411 | -$2.0M |
| Interest expense | $1.8M | — | $1.2M | $2.1M | — |
| Pretax income | -$24.1M | — | $1.2M | -$2.1M | -$450,186 |
| Income tax expense | $0 | — | $0 | $3,787 | $250,739 |
| Net income | -$23.7M | — | $1.2M | -$2.1M | -$700,925 |
| Balance Sheet | |||||
| Cash and equivalents | $5.3M | — | $38,742 | $607,869 | $809,481 |
| Current assets | $8.0M | — | $10.9M | $8.4M | $1.1M |
| Total assets | $33.5M | — | $25.6M | $20.8M | $118.3M |
| Current liabilities | $16.9M | — | $18.7M | $14.1M | — |
| Total liabilities | $17.2M | — | $20.2M | $15.5M | $1.2M |
| Stockholders' equity | $20.1M | $10.4M | $3.5M | $5.2M | $5.0M |
| Cash Flow Statement | |||||
| Cash from operations | -$12.1M | — | -$1.4M | -$2.0M | -$1.3M |
| Depreciation and amortization | $20,321 | — | $13,341 | $25,822 | — |
| Stock-based compensation | $3.9M | — | $10,000 | $327,499 | — |
| Capital expenditure | $455,000 | — | $448,000 | $12,774 | — |
| Free cash flow | -$12.5M | — | -$1.8M | -$2.0M | — |
| Share repurchases | $1.0M | — | $0 | $114.3M | — |
| Impairments | — | — | $0 | $0 | — |
Shares outstanding 8.6M · Free float 47.8%
Annual filing data through FY ended December 31, 2025; float as of July 4, 2026.